Black Diamond Therapeutics, Inc. BDTX
Set alert
1.78 USD -0.08 -4.30%
At close · Oct 30
1.78 0.00 0.00%
After hours · Oct 30, 7:28 PM ET
1.76 Day range 1.90
1.61 52-week range 4.87
- YTD
- -26.75%
- 1 year
- -53.40%
- Open
- 1.86
- Prev close
- 1.86
- Mkt cap
- 102.27M
- Vol
- 520.16K
- Avg vol
- 685.61K
- EPS
- -0.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.76
- High
- 1.90
- Forward P/E
- -1.80
- Beta
- 2.52
- Short ratio
- 11.67
- Inst. own
- 98.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 2.79
- 200-d avg
- 4.63
- 1y target
- 14.50
Financial health
Altman Z-Score
-3.43 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E 6.2×
FY 2017 5y median -1.5× FY 2025
P/S 2.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.2×
FY 2017 5y median 1.1× FY 2025
P/FCF 4.7×
FY 2017 5y median -1.9× FY 2025
EV/EBITDA 6.0×
FY 2017 5y median -1.1× FY 2025
EV/Sales 1.9×
FY 2017 5y median 0.0× FY 2025
FCF Yield 21.4%
FY 2017 5y median -53.3% FY 2025
Profitability
Gross Margin 99.5%
FY 2017 5y median 0.0% FY 2025
Operating Margin 28.4%
FY 2017 5y median 0.0% FY 2025
Net Margin 32.0%
FY 2017 5y median 0.0% FY 2025
ROE 19.9%
FY 2017 5y median -70.6% FY 2025
ROIC 15.2%
FY 2017 5y median -60.9% FY 2025
ROA 15.6%
FY 2017 5y median -52.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income 125.2%
FY 2017 FY 2025
EPS (diluted) 130.7%
FY 2017 FY 2025
Free Cash Flow 147.5%
FY 2017 FY 2025
Financial Health
Current Ratio 8.4×
FY 2017 5y median 8.4× FY 2025
Quick Ratio 8.4×
FY 2017 5y median 8.4× FY 2025
Debt / Equity 0.2×
FY 2017 5y median 0.2× FY 2025
Net Debt / EBITDA -0.1×
FY 2017 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31